JP4301443B2 - Hair growth agent and patch containing the hair growth agent - Google Patents
Hair growth agent and patch containing the hair growth agent Download PDFInfo
- Publication number
- JP4301443B2 JP4301443B2 JP2004029878A JP2004029878A JP4301443B2 JP 4301443 B2 JP4301443 B2 JP 4301443B2 JP 2004029878 A JP2004029878 A JP 2004029878A JP 2004029878 A JP2004029878 A JP 2004029878A JP 4301443 B2 JP4301443 B2 JP 4301443B2
- Authority
- JP
- Japan
- Prior art keywords
- musk
- synthetic
- synthetic musk
- butylbenzene
- acetyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000003779 hair growth Effects 0.000 title description 17
- 241000402754 Erythranthe moschata Species 0.000 claims description 81
- 210000004209 hair Anatomy 0.000 claims description 39
- -1 5-acetyltetramethylisopropylindane (5-acetyl-3-isopropyl-1,1,2,6-tetramethylindane) Chemical compound 0.000 claims description 37
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 claims description 36
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 claims description 24
- LOKPJYNMYCVCRM-UHFFFAOYSA-N 16-Hexadecanolide Chemical compound O=C1CCCCCCCCCCCCCCCO1 LOKPJYNMYCVCRM-UHFFFAOYSA-N 0.000 claims description 10
- FKUPPRZPSYCDRS-UHFFFAOYSA-N Cyclopentadecanolide Chemical compound O=C1CCCCCCCCCCCCCCO1 FKUPPRZPSYCDRS-UHFFFAOYSA-N 0.000 claims description 10
- OSOIQJGOYGSIMF-UHFFFAOYSA-N cyclopentadecanone Chemical compound O=C1CCCCCCCCCCCCCC1 OSOIQJGOYGSIMF-UHFFFAOYSA-N 0.000 claims description 10
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 10
- ALHUZKCOMYUFRB-UHFFFAOYSA-N 3-methylcyclopentadecan-1-one Chemical compound CC1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-UHFFFAOYSA-N 0.000 claims description 8
- GJJSUPSPZIZYPM-UHFFFAOYSA-N 1,4-dioxacyclohexadecane-5,16-dione Chemical compound O=C1CCCCCCCCCCC(=O)OCCO1 GJJSUPSPZIZYPM-UHFFFAOYSA-N 0.000 claims description 5
- MRMOPGVGWFNHIN-UHFFFAOYSA-N 1,6-dioxacycloheptadecan-7-one Chemical compound O=C1CCCCCCCCCCOCCCCO1 MRMOPGVGWFNHIN-UHFFFAOYSA-N 0.000 claims description 5
- MZLRFHKWWCSGHB-UHFFFAOYSA-N 1,8-dioxacycloheptadecan-9-one Chemical compound O=C1CCCCCCCCOCCCCCCO1 MZLRFHKWWCSGHB-UHFFFAOYSA-N 0.000 claims description 5
- VDBHOHJWUDKDRW-UHFFFAOYSA-N 1-(1,1,2,3,3,6-hexamethyl-2h-inden-5-yl)ethanone Chemical compound CC1=C(C(C)=O)C=C2C(C)(C)C(C)C(C)(C)C2=C1 VDBHOHJWUDKDRW-UHFFFAOYSA-N 0.000 claims description 5
- MINYPECWDZURGR-UHFFFAOYSA-N 1-tert-butyl-3,4,5-trimethyl-2,6-dinitrobenzene Chemical compound CC1=C(C)C([N+]([O-])=O)=C(C(C)(C)C)C([N+]([O-])=O)=C1C MINYPECWDZURGR-UHFFFAOYSA-N 0.000 claims description 5
- QYZSCAXYTWMYHH-UHFFFAOYSA-N 2,2,3,3,4,4-hexamethyl-5,6-dihydro-4ah-cyclopenta[h]chromene Chemical compound C1CC2C(C)(C)C(C)(C)C(C)(C)OC2=C2C=CC=C21 QYZSCAXYTWMYHH-UHFFFAOYSA-N 0.000 claims description 5
- FACFHHMQICTXFZ-UHFFFAOYSA-N 2-(2-phenylimidazo[1,2-a]pyridin-3-yl)ethanamine Chemical compound N1=C2C=CC=CN2C(CCN)=C1C1=CC=CC=C1 FACFHHMQICTXFZ-UHFFFAOYSA-N 0.000 claims description 5
- DNRJTBAOUJJKDY-UHFFFAOYSA-N 2-Acetyl-3,5,5,6,8,8-hexamethyl-5,6,7,8- tetrahydronaphthalene Chemical compound CC(=O)C1=C(C)C=C2C(C)(C)C(C)CC(C)(C)C2=C1 DNRJTBAOUJJKDY-UHFFFAOYSA-N 0.000 claims description 5
- IARKSBSXAUOKHP-UHFFFAOYSA-N 3-tert-butyl-2,4-dimethyl-1,5-dinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C)=C1C(C)(C)C IARKSBSXAUOKHP-UHFFFAOYSA-N 0.000 claims description 5
- JLSNCMRKRFCIHU-UHFFFAOYSA-N C1(CCCC=CCCCCCCCCCC1)=O.C1(C=CCCCCCCCCCCCCC1)=O Chemical compound C1(CCCC=CCCCCCCCCCC1)=O.C1(C=CCCCCCCCCCCCCC1)=O JLSNCMRKRFCIHU-UHFFFAOYSA-N 0.000 claims description 5
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 5
- 239000005977 Ethylene Substances 0.000 claims description 5
- SUAUILGSCPYJCS-UHFFFAOYSA-N Musk ambrette Chemical compound COC1=C([N+]([O-])=O)C(C)=C([N+]([O-])=O)C=C1C(C)(C)C SUAUILGSCPYJCS-UHFFFAOYSA-N 0.000 claims description 5
- ZRCIIOJLEHKCSZ-UHFFFAOYSA-N cyclopentadec-7-en-1-one Chemical compound O=C1CCCCCCCC=CCCCCC1 ZRCIIOJLEHKCSZ-UHFFFAOYSA-N 0.000 claims description 5
- 229940067137 musk ketone Drugs 0.000 claims description 5
- XMWRWTSZNLOZFN-UHFFFAOYSA-N musk xylene Chemical compound CC1=C(N(=O)=O)C(C)=C(N(=O)=O)C(C(C)(C)C)=C1N(=O)=O XMWRWTSZNLOZFN-UHFFFAOYSA-N 0.000 claims description 5
- MKEIDVFLAWJKMY-UHFFFAOYSA-N 1,7-dioxacycloheptadecan-8-one Chemical compound O=C1CCCCCCCCCOCCCCCO1 MKEIDVFLAWJKMY-UHFFFAOYSA-N 0.000 claims description 4
- QFRZEGADDLNLLM-UHFFFAOYSA-N oxacyclohexadecane-2,13-dione Chemical compound O=C1CCCCCCCCCCC(=O)OCCC1 QFRZEGADDLNLLM-UHFFFAOYSA-N 0.000 claims description 3
- FNPLANJZWITHDG-UHFFFAOYSA-N oxacyclohexadecane Chemical compound C1CCCCCCCOCCCCCCC1 FNPLANJZWITHDG-UHFFFAOYSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 22
- 239000000126 substance Substances 0.000 description 20
- 239000004480 active ingredient Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 239000000853 adhesive Substances 0.000 description 10
- 230000001070 adhesive effect Effects 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 229920003169 water-soluble polymer Polymers 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 210000004761 scalp Anatomy 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000005038 ethylene vinyl acetate Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LEDVOQYZMOLCIX-UHFFFAOYSA-N 1-(1,2,2,3-tetramethyl-1-propan-2-yl-3h-inden-5-yl)ethanone Chemical compound C1=C(C(C)=O)C=C2C(C)C(C)(C)C(C(C)C)(C)C2=C1 LEDVOQYZMOLCIX-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- ALHUZKCOMYUFRB-OAHLLOKOSA-N Muscone Chemical compound C[C@@H]1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-OAHLLOKOSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229940031578 diisopropyl adipate Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000005033 polyvinylidene chloride Substances 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 229920006132 styrene block copolymer Polymers 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IMRYETFJNLKUHK-SJKOYZFVSA-N 1-[(2r,3r)-1,1,2,6-tetramethyl-3-propan-2-yl-2,3-dihydroinden-5-yl]ethanone Chemical compound CC1=C(C(C)=O)C=C2[C@H](C(C)C)[C@@H](C)C(C)(C)C2=C1 IMRYETFJNLKUHK-SJKOYZFVSA-N 0.000 description 1
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- ZKVZSBSZTMPBQR-UHFFFAOYSA-N Civetone Natural products O=C1CCCCCCCC=CCCCCCCC1 ZKVZSBSZTMPBQR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 241001416180 Moschidae Species 0.000 description 1
- 241000972170 Moschus moschiferus Species 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- SSOXZAQUVINQSA-BTJKTKAUSA-N Pheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=CC=C1 SSOXZAQUVINQSA-BTJKTKAUSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- XQTARQNQIVVBRX-UHFFFAOYSA-N Tazanolast Chemical compound CCCCOC(=O)C(=O)NC1=CC=CC(C2=NNN=N2)=C1 XQTARQNQIVVBRX-UHFFFAOYSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- SGRYPYWGNKJSDL-UHFFFAOYSA-N amlexanox Chemical compound NC1=C(C(O)=O)C=C2C(=O)C3=CC(C(C)C)=CC=C3OC2=N1 SGRYPYWGNKJSDL-UHFFFAOYSA-N 0.000 description 1
- 229960003731 amlexanox Drugs 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 229960004574 azelastine Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- ZKVZSBSZTMPBQR-UPHRSURJSA-N civetone Chemical compound O=C1CCCCCCC\C=C/CCCCCCC1 ZKVZSBSZTMPBQR-UPHRSURJSA-N 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940109248 cromoglycate Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229960004646 diphenhydramine tannate Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229960003630 ketotifen fumarate Drugs 0.000 description 1
- YNQQEYBLVYAWNX-WLHGVMLRSA-N ketotifen fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 YNQQEYBLVYAWNX-WLHGVMLRSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 239000001700 moschus moschiferus Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BAINIUMDFURPJM-UHFFFAOYSA-N oxatomide Chemical compound O=C1NC2=CC=CC=C2N1CCCN(CC1)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 BAINIUMDFURPJM-UHFFFAOYSA-N 0.000 description 1
- 229960002698 oxatomide Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229960001339 pheniramine maleate Drugs 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000012985 polymerization agent Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229950011558 tazanolast Drugs 0.000 description 1
- 229960000351 terfenadine Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- NZHGWWWHIYHZNX-CSKARUKUSA-N tranilast Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C(=O)NC1=CC=CC=C1C(O)=O NZHGWWWHIYHZNX-CSKARUKUSA-N 0.000 description 1
- 229960005342 tranilast Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Description
本発明は育毛剤及び該育毛剤を含有する貼布剤に関する。本発明の目的は、経皮吸収性に優れた育毛剤及び、皮膚局所に直接貼って使用することで、育毛剤を長時間にわたって徐々に経皮吸収させて、優れた育毛効果を発揮することができる貼布剤を提供することにある。 The present invention relates to a hair restorer and a patch containing the hair restorer. An object of the present invention is to provide a hair growth agent excellent in transdermal absorbability and to be used by being directly applied to the skin, thereby gradually absorbing the hair growth agent over a long period of time and exhibiting an excellent hair growth effect. It is in providing the patch which can do.
脱毛症の大部分を占める男性型脱毛症には、「男性ホルモン」が関与していることが知られている。
テストステロンなどの男性ホルモンはそのままの形では活性は低い。しかし、皮脂腺には還元酵素5−α−リダクターゼが存在しており、テストステロンは活性の高い5−α−デヒドロテストステロン(DHT)に還元される。DHTは毛母細胞が取り込んだ栄養成分を細胞分裂に必要とされるエネルギーに変換することを阻害するために、毛母細胞は細胞分裂に必要なエネルギーを生産することができず、これが、脱毛症の原因の一つと考えられている。
従って、テストステロンなどの男性ホルモンを活性の高いDHTに還元する5−α−リダクターゼの活性を阻害することで、脱毛症の予防や治療を行うことができると考えられる。5−α−リダクターゼの阻害剤としては、エストラジオールなどの女性ホルモン(特許文献1参照)が知られているが、副作用の危険性が高く、広く普及するに至っていない。
It is known that “male hormone” is involved in male pattern baldness, which accounts for the majority of alopecia.
Male hormones such as testosterone are less active as they are. However, reductase 5-α-reductase is present in the sebaceous glands, and testosterone is reduced to highly active 5-α-dehydrotestosterone (DHT). Since DHT inhibits the conversion of nutrients taken up by hair matrix cells into the energy required for cell division, hair matrix cells cannot produce the energy required for cell division, which It is considered one of the causes of the disease.
Therefore, it is considered that alopecia can be prevented or treated by inhibiting the activity of 5-α-reductase that reduces male hormones such as testosterone to highly active DHT. As an inhibitor of 5-α-reductase, female hormones such as estradiol (see Patent Document 1) are known, but they have a high risk of side effects and have not been widely spread.
一方、脱毛症の他の原因としては、毛母細胞の機能低下を挙げることができる。毛母細胞の機能を正常に戻すことができれば、脱毛を予防し、発毛を促進することができると考えられる。
毛母細胞の機能を正常化することができると考えられているものとして、細胞増殖因子、血行促進剤、毛母細胞賦活剤などが知られている。
細胞増殖因子としては、ジアルキルモノアミン誘導体、マイカイ花エキス、イチョウエキス、感光素301号、チョウレイエキス、サンザシエキス、グロスフェリン、プラセンタエキス、インスリン様成長因子(IGF・I)などが知られている。
血行促進剤としては、センブリエキス、酢酸トコフェロール、ニコチン酸ベンジル、トウガラシチンキ、ミノキシジル、塩化カルプロニウムなどが知られている。
毛母細胞賦活剤としては、ペンタデカン酸グリセリド、6−ベンジルアミノプリン(特許文献2参照)などが知られている。
On the other hand, other causes of alopecia can include reduced function of hair matrix cells. If the function of the hair matrix cells can be restored to normal, it is considered that hair loss can be prevented and hair growth can be promoted.
Cell growth factors, blood circulation promoters, hair matrix cell activators, and the like are known as those that are thought to be able to normalize the function of hair matrix cells.
Known cell growth factors include dialkyl monoamine derivatives, maikai flower extract, ginkgo biloba extract, photosensitizer 301, butterfly extract, hawthorn extract, grosferrin, placenta extract, insulin-like growth factor (IGF · I), and the like. .
Known blood circulation promoters include assembly extract, tocopherol acetate, benzyl nicotinate, chili pepper, minoxidil, carpronium chloride and the like.
Known hair matrix cell activators include pentadecanoic acid glycerides and 6-benzylaminopurine (see Patent Document 2).
現在一般に市販されている育毛剤組成物は、頭皮にふりかけたり、頭皮に塗布したり、或いは頭皮に直接塗り込んだりして使用するものが殆どである。育毛剤組成物中の有効成分は毛母細胞或いはその周辺で作用するものであるから、有効成分を毛乳頭にまで供給させないと、育毛効果を得ることはできない。
頭皮から毛乳頭にまで育毛剤組成物の有効成分を浸透させるには、有効成分を毛孔から毛包側壁を通過させなければならない。しかしながら、毛孔や毛包内は分泌された皮脂によって親油性の状態になっており、普通にシャンプーをして毛孔周辺をきれいにしたとしても、毛包内部は皮脂が詰まったままの状態であり、水溶性である育毛剤組成物の有効成分は毛母細胞の周辺に浸透し難い。
Most of the hair restorer compositions that are currently commercially available are used by being sprinkled on the scalp, applied to the scalp, or applied directly to the scalp. Since the active ingredient in the hair restorer composition acts on the hair matrix cells or the vicinity thereof, the hair restoration effect cannot be obtained unless the active ingredient is supplied to the hair papilla.
In order to penetrate the active ingredient of the hair-growing composition from the scalp to the hair papilla, the active ingredient must pass through the follicle side wall from the pores. However, the pores and hair follicles are in a lipophilic state due to the secreted sebum, and even if the area around the pores is cleaned by shampooing normally, the inside of the hair follicle is still clogged with sebum, The active ingredient of the hair-restoring composition that is water-soluble hardly penetrates around the hair matrix cells.
従って、従来の育毛剤組成物は一日に複数回使用することで、育毛効果を得ようとしている。しかしながら、従来の育毛剤組成物を一日に複数回使用したとしても、使用直後は有効成分の頭皮への供給量は増えるが、有効成分を長時間にわたって供給することはできず、十分な育毛効果を得ることは困難であった。また、従来の育毛剤組成物のように、一日に複数回使用する場合、使用することを忘れてしまったり、或いは忙しい時には使用することができない場合があり、従来の育毛剤組成物は長期間継続して使用することが困難であった。 Therefore, the conventional hair-restoring agent composition is going to acquire the hair-restoration effect by using it several times a day. However, even if the conventional hair restorer composition is used multiple times a day, the amount of active ingredient supplied to the scalp increases immediately after use, but the active ingredient cannot be supplied over a long period of time, and sufficient hair restoration is possible. It was difficult to obtain an effect. In addition, when used multiple times a day as in the conventional hair restorer composition, it may be forgotten to be used or may not be used when busy, and the conventional hair restorer composition is long. It was difficult to use continuously for a period.
本発明は上記した課題を解決するためになされた発明であり、請求項1に係る発明は、 以下の(A)大環状合成ムスク、(B)ニトロ系合成ムスク、(C)インダン系合成ムスク及び(D)テトラリン系合成ムスクからなる群から選択される1種以上からなることを特徴とする育毛剤に関する。 The present invention has been made to solve the above problems, and the invention according to claim 1 includes the following (A) macrocyclic synthetic musk, (B) nitro synthetic musk, (C) indane synthetic musk. And (D) a hair growth agent comprising at least one selected from the group consisting of tetralin synthetic musks.
(A)大環状合成ムスク(A) Macrocyclic synthetic musk
シベトン(9−シクロペンタデセン−1−オン)、シクロペンタデカノン、シクロヘキサデセノン(5−シクロヘキサデセン−1−オン)、シクロペンタデカノリド、12−ケトシクロペンタデカノリド(オキサシクロヘキサデカン−2,13−ジオン)、シクロヘキサデカノリド、シクロヘキサデセノリド(7−シクロヘキサデセノリド)、12−オキサ−16−ヘキサデカノリド、11−オキサ−16−ヘキサデカノリド、10−オキサ−16−ヘキサデカノリド、エチレンプラシレート、エチレンドデカンジオエート Cybeton (9-cyclopentadecene-1-one), cyclopentadecanone, cyclohexadecenone (5-cyclohexadecene-1-one), cyclopentadecanolide, 12-ketocyclopentadecanolide (oxacyclohexadecane) -2,13-dione), cyclohexadecanolide, cyclohexadecenolide (7-cyclohexadecenolide), 12-oxa-16-hexadecanolide, 11-oxa-16-hexadecanolide, 10-oxa-16-hexadecanolide , Ethylene plasylate, ethylene dodecanedioate
(B)ニトロ系合成ムスク(B) Nitro-based synthetic musk
ムスクケトン(2,6−ジニトロ−3,5−ジメチル−4−t−ブチルベンゼン)、ムスクキシロール(2,4,6−トリニトロ−5−t−ブチルベンゼン)、ムスクアンブレット(2,6−ジニトロ−3−メトキシ−1−メチル−4−t−ブチルベンゼン)、ムスクチベテン(2,6−ジニトロ−3,4,5−トリメチル−t−ブチルベンゼン)、ムスクモスケン(1,1,3,3,5−ペンタメチル−4,6−ジニトロインダン) Musk ketone (2,6-dinitro-3,5-dimethyl-4-tert-butylbenzene), musk xylol (2,4,6-trinitro-5-tert-butylbenzene), musk ambullet (2,6-dinitro -3-Methoxy-1-methyl-4-t-butylbenzene), Muscutibeten (2,6-dinitro-3,4,5-trimethyl-t-butylbenzene), Musk Mosken (1,1,3,3,5) -Pentamethyl-4,6-dinitroindane)
(C)インダン系合成ムスク(C) Indan synthetic musk
6−アセチルヘキサメチルインダリン(6−アセチル−1,1,2,3,3,5−ヘキサメチルインダン)、4−アセチルジメチル−t−ブチルインダリン(4−アセチル−6−t−ブチル−1,1−ジメチルインダリン)、5−アセチルテトラメチルイソプロピルインダン(5−アセチル−3−イソプロピル−1,1,2,6−テトラメチルインダン) 6-acetylhexamethylindarin (6-acetyl-1,1,2,3,3,5-hexamethylindane), 4-acetyldimethyl-t-butylindarin (4-acetyl-6-t-butyl-) 1,1-dimethylindyne), 5-acetyltetramethylisopropylindane (5-acetyl-3-isopropyl-1,1,2,6-tetramethylindane)
(D)テトラリン系合成ムスク(D) Tetralin-based synthetic musk
6−アセチルヘキサテトラリン(6−アセチル−1,1,2,4,4,7−ヘキサメチルテトラリン)、ヘキサメチルヘキサヒドロシクロペンタベンゾピラン(4,6,6,7,8,8−ヘキサメチル−1,3,4,6,7,8−ヘキサヒドロシクロペンタベンゾピラン) 6-acetylhexatetralin (6-acetyl-1,1,2,4,4,7-hexamethyltetralin), hexamethylhexahydrocyclopentabenzopyran (4,6,6,7,8,8-hexamethyl- 1,3,4,6,7,8-hexahydrocyclopentabenzopyran)
請求項2に係る発明は以下の(A)大環状合成ムスク、(B)ニトロ系合成ムスク,(C)インダン系合成ムスク及び(D)テトラリン系合成ムスクからなる群から選択される1種以上が含有されていることを特徴とする育毛用貼付剤に関する。 The invention according to claim 2 is one or more selected from the group consisting of the following (A) macrocyclic synthetic musk, (B) nitro synthetic musk, (C) indane synthetic musk and (D) tetralin synthetic musk. It is related with the patch for hair growth characterized by containing.
(A)大環状合成ムスク(A) Macrocyclic synthetic musk
ムスコン(3−メチルシクロペンタデカノン)、シベトン(9−シクロペンタデセン−1−オン)、シクロペンタデカノン、シクロヘキサデセノン(5−シクロヘキサデセン−1−オン)、シクロペンタデカノリド、12−ケトシクロペンタデカノリド(オキサシクロヘキサデカン−2,13−ジオン)、シクロヘキサデカノリド、シクロヘキサデセノリド(7−シクロヘキサデセノリド)、12−オキサ−16−ヘキサデカノリド、11−オキサ−16−ヘキサデカノリド、10−オキサ−16−ヘキサデカノリド、エチレンプラシレート、エチレンドデカンジオエート Muscone (3-methylcyclopentadecanone), civetone (9-cyclopentadecene-1-one), cyclopentadecanone, cyclohexadecenone (5-cyclohexadecen-1-one), cyclopentadecanolide, 12 -Ketocyclopentadecanolide (oxacyclohexadecane-2,13-dione), cyclohexadecanolide, cyclohexadecenolide (7-cyclohexadecenolide), 12-oxa-16-hexadecanolide, 11-oxa- 16-hexadecanolide, 10-oxa-16-hexadecanolide, ethylene plasylate, ethylenedodecanedioate
(B)ニトロ系合成ムスク(B) Nitro-based synthetic musk
ムスクケトン(2,6−ジニトロ−3,5−ジメチル−4−t−ブチルベンゼン)、ムスクキシロール(2,4,6−トリニトロ−5−t−ブチルベンゼン)、ムスクアンブレット(2,6−ジニトロ−3−メトキシ−1−メチル−4−t−ブチルベンゼン)、ムスクチベテン(2,6−ジニトロ−3,4,5−トリメチル−t−ブチルベンゼン)、ムスクモスケン(1,1,3,3,5−ペンタメチル−4,6−ジニトロインダン) Musk ketone (2,6-dinitro-3,5-dimethyl-4-tert-butylbenzene), musk xylol (2,4,6-trinitro-5-tert-butylbenzene), musk ambullet (2,6-dinitro -3-Methoxy-1-methyl-4-t-butylbenzene), Muscutibeten (2,6-dinitro-3,4,5-trimethyl-t-butylbenzene), Musk Mosken (1,1,3,3,5) -Pentamethyl-4,6-dinitroindane)
(C)インダン系合成ムスク(C) Indan synthetic musk
6−アセチルヘキサメチルインダリン(6−アセチル−1,1,2,3,3,5−ヘキサメチルインダン)4−アセチルジメチル−t−ブチルインダリン(4−アセチル−6−t−ブチル−1,1−ジメチルインダリン)、5−アセチルテトラメチルイソプロピルインダン(5−アセチル−3−イソプロピル−1,1,2,6−テトラメチルインダン) 6-acetylhexamethylindarin (6-acetyl-1,1,2,3,3,5-hexamethylindane) 4-acetyldimethyl-t-butylindarin (4-acetyl-6-t-butyl-1) , 1-dimethylindalin), 5-acetyltetramethylisopropylindane (5-acetyl-3-isopropyl-1,1,2,6-tetramethylindane)
(D)テトラリン系合成ムスク(D) Tetralin-based synthetic musk
6−アセチルヘキサテトラリン(6−アセチル−1,1,2,4,4,7−ヘキサメチルテトラリン)、ヘキサメチルヘキサヒドロシクロペンタベンゾピラン(4,6,6,7,8,8−ヘキサメチル−1,3,4,6,7,8−ヘキサヒドロシクロペンタベンゾピラン) 6-acetylhexatetralin (6-acetyl-1,1,2,4,4,7-hexamethyltetralin), hexamethylhexahydrocyclopentabenzopyran (4,6,6,7,8,8-hexamethyl- 1,3,4,6,7,8-hexahydrocyclopentabenzopyran)
請求項3に係る発明は、支持体と、該支持体に含浸又は積層された基剤層とからなり、該基剤層には請求項2に記載の(A)大環状合成ムスク、(B)ニトロ系合成ムスク,(C)インダン系合成ムスク及び(D)テトラリン系合成ムスクからなる群から選択される1種以上が含有されていることを特徴とする育毛用貼付剤に関する。 The invention according to claim 3 includes a support and a base layer impregnated or laminated on the support, and the base layer includes (A) a macrocyclic synthetic musk according to claim 2, (B The present invention relates to a hair growth patch comprising one or more selected from the group consisting of :) a nitro-based synthetic musk, (C) an indane-based synthetic musk, and (D) a tetralin-based synthetic musk.
本発明に係る育毛剤は優れた育毛効果を有する。しかも、本発明に係る育毛剤は経皮吸収性に優れるので、従来の育毛剤に比べて優れた育毛効果を発揮することができる。
本発明に係る貼布剤は皮膚局所に直接貼って使用することで、基剤層に含まれる育毛剤を長時間にわたって徐々に経皮吸収させることができ、優れた育毛効果を発揮することが可能である。また、本発明に係る貼布剤は皮膚局所に貼るだけで、長時間にわたって育毛剤を徐々に経皮吸収させることができるので、従来の育毛剤組成物に比べて手軽に使用することができる。
The hair restorer according to the present invention has an excellent hair growth effect. And since the hair restorer which concerns on this invention is excellent in percutaneous absorbability, it can exhibit the hair growth effect outstanding compared with the conventional hair restorer.
The patch according to the present invention can be used by directly sticking to the skin topical area, so that the hair restorer contained in the base layer can be gradually percutaneously absorbed over a long period of time, and an excellent hair restorer effect can be exhibited. Is possible. In addition, since the patch according to the present invention can be gradually percutaneously absorbed over a long period of time simply by sticking it on the skin, it can be used more easily than conventional hair restorer compositions. .
以下、本発明について詳細に説明する。本発明に係る貼布剤は必須成分として、ムスク様香気を有する香料成分を含有する。
ムスクはジャコウとも呼ばれ、ジャコウジカ(Moschus moschiferus L.)の雄の腹部にある香のうの分泌物を乾燥したものである。ジャコウジカの商取引はワシントン条約で禁止されており、非常に高価である。
Hereinafter, the present invention will be described in detail. The patch according to the present invention contains a fragrance component having a musk-like fragrance as an essential component.
Musk, also called musk, is a dried scented secretion in the male abdomen of musk deer (Moschus moschiferus L.). Musk commerce is prohibited by the Washington Convention and is very expensive.
本発明では、ムスク様香気を有する香料成分が育毛剤の有効成分である。本発明者らは、後述する試験例に示されるように、ムスク様香気を有する香料成分が育毛効果を有することを実験的に見出した。特に、ムスク様香気を有する香料成分を皮膚局所から経皮吸収させることで、優れた育毛効果を発揮することができる。
ムスク様の香気を有する香料成分としてムスクを使用することもできるが、ムスクは非常に高価であるとともに、必要量を長期間安定的に確保することが困難であるので、本発明では合成ムスクを使用する。合成ムスクとは、ムスクに含まれる香料成分を化学合成したもの、又はムスクと類似する香気を有する香料成分を化学合成したもの、或いはムスクに含まれる香料成分と類似する構造を有する香料成分を化学合成したものであり、いずれもムスク様の香気を有する。
合成ムスクの具体例としては、大環状合成ムスク、ニトロ系合成ムスク、インダン系合成ムスク、テトラリン系合成ムスクなどを例示することができる。
In this invention, the fragrance | flavor component which has a musk-like fragrance is an active ingredient of a hair restorer. The present inventors experimentally found that a perfume component having a musk-like aroma has a hair-growth effect, as shown in Test Examples described later. In particular, an excellent hair-growth effect can be exhibited by percutaneously absorbing a fragrance component having a musk-like fragrance from the skin local area.
Although musk can be used as a fragrance component having a musk-like fragrance, musk is very expensive and it is difficult to stably secure the required amount for a long period of time. use. A synthetic musk is a chemical synthesis of a perfume component contained in a musk, a chemical synthesis of a perfume component having an aroma similar to a musk, or a perfume component having a structure similar to a perfume component contained in a musk. They are synthesized and both have a musk-like aroma.
Specific examples of synthetic musks include macrocyclic synthetic musks, nitro synthetic musks, indane synthetic musks, and tetralin synthetic musks.
大環状合成ムスクとしては、化1の(1)に示されるムスコン(3−メチルシクロペンタデカノン)、化1の(2)に示されるシベトン(9−シクロペンタデセン−1−オン)、化1の(3)に示されるシクロペンタデカノン、化1の(4)に示されるシクロヘキサデセノン(5−シクロヘキサデセン−1−オン)、化1の(5)に示されるシクロペンタデカノリド、化1の(6)に示される12−ケトシクロペンタデカノリド(オキサシクロヘキサデカン−2,13−ジオン)、化2の(7)に示されるシクロヘキサデカノリド、化2の(8)に示されるシクロヘキサデセノリド(7−シクロヘキサデセノリド)、化2の(9)に示される12−オキサ−16−ヘキサデカノリド、化2の(10)に示される11−オキサ−16−ヘキサデカノリド、化2の(11)に示される10−オキサ−16−ヘキサデカノリド、化2の(12)に示されるエチレンプラシレート、化2の(13)に示されるエチレンドデカンジオエートなどを例示することができる。 As the macrocyclic synthetic musk, muscone (3-methylcyclopentadecanone) represented by (1) in Chemical Formula 1, sibetone (9-cyclopentadecene-1-one) represented by (2) in Chemical Formula 1, 1, cyclopentadecanone represented by (3), cyclohexadecenone (5-cyclohexadecen-1-one) represented by chemical formula (4), cyclopentadecanolide represented by chemical formula (5) 12-ketocyclopentadecanolide (oxacyclohexadecane-2,13-dione) represented by (6) in Chemical Formula 1, cyclohexadecanolide represented by (7) in Chemical Formula 2, (8) ), 12-oxa-16-hexadecanolide represented by chemical formula (9), and 11-oxa-16-hexadecene represented by chemical formula (10). Exemplifying nolide, 10-oxa-16-hexadecanolide shown in (11) of Chemical Formula 2, ethylene plasylate shown in (12) of Chemical Formula 2, ethylenedodecanedioate shown in (13) of Chemical Formula 2 Can do.
ニトロ系ムスクとしては、化3の(1)に示されるムスクケトン(2,6−ジニトロ−3,5−ジメチル−4−t−ブチルベンゼン)、化3の(2)に示されるムスクキシロール(2,4,6−トリニトロ−5−t−ブチルベンゼン)、化3の(3)に示されるムスクアンブレット(2,6−ジニトロ−3−メトキシ−1−メチル−4−t−ブチルベンゼン)、化3の(4)に示されるムスクチベテン(2,6−ジニトロ−3,4,5−トリメチル−t−ブチルベンゼン)、化3の(5)に示されるムスクモスケン(1,1,3,3,5−ペンタメチル−4,6−ジニトロインダン)などを例示することができる。 Examples of the nitro musk include musk ketone (2,6-dinitro-3,5-dimethyl-4-tert-butylbenzene) represented by chemical formula (1) and musk xylol represented by chemical formula (2) (2). , 4,6-trinitro-5-t-butylbenzene), musk emblet (2,6-dinitro-3-methoxy-1-methyl-4-t-butylbenzene) represented by (3) of Chemical formula 3, Muscutibeten (2,6-dinitro-3,4,5-trimethyl-t-butylbenzene) represented by (3) in Chemical Formula 3, Musk Mosken (1,1,3,3,3) represented by (5) in Chemical Formula 3 5-pentamethyl-4,6-dinitroindane) and the like.
インダン系ムスクとしては、化4の(1)に示される6−アセチルヘキサメチルインダリン(6−アセチル−1,1,2,3,3,5−ヘキサメチルインダン)、化4の(2)に示される4−アセチルジメチル−t−ブチルインダリン(4−アセチル−6−t−ブチル−1,1−ジメチルインダリン)、化4の(3)に示される5−アセチルテトラメチルイソプロピルインダン(5−アセチル−3−イソプロピル−1,1,2,6−テトラメチルインダン)などを例示することができる。 Examples of the indane musk include 6-acetylhexamethylindarin (6-acetyl-1,1,2,3,3,5-hexamethylindane) represented by chemical formula (1) and chemical formula (2). 4-acetyldimethyl-t-butylindarin (4-acetyl-6-t-butyl-1,1-dimethylindalin) represented by formula (5), 5-acetyltetramethylisopropylindane (3) represented by formula (3) 5-acetyl-3-isopropyl-1,1,2,6-tetramethylindane) and the like.
テトラリン系ムスクとしては、化4の(4)に示される6−アセチルヘキサテトラリン(6−アセチル−1,1,2,4,4,7−ヘキサメチルテトラリン)、化4の(5)に示されるヘキサメチルヘキサヒドロシクロペンタベンゾピラン(4,6,6,7,8,8−ヘキサメチル−1,3,4,6,7,8−ヘキサヒドロシクロペンタベンゾピラン)などを例示することができる。 Examples of tetralin-based musks include 6-acetylhexatetralin (6-acetyl-1,1,2,4,4,7-hexamethyltetralin) represented by chemical formula (4) and chemical formula (5). Hexamethylhexahydrocyclopentabenzopyran (4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopentabenzopyran) and the like can be exemplified. .
本発明では、上述した合成ムスクのうち、一種類の合成ムスクを単独で使用することもでき、或いは二種類以上の合成ムスクの混合物として使用することもできる。
上述した合成ムスクは後述する基剤層中に配合されて本発明に係る貼布剤とされるが、基剤層中における合成ムスクの含有量は特に限定されないが、基剤層100重量部当り、0.0001〜10重量部、好ましくは0.001〜7重量部、より好ましくは0.01〜5重量部である。0.0001重量部未満であると、育毛効果を発揮し難くなり、10重量部を超えると、それ以上の育毛効果が得られないばかりか、ムスク様の香気が強くなり好ましくない。
In the present invention, among the synthetic musks described above, one type of synthetic musk can be used alone, or a mixture of two or more types of synthetic musks can be used.
The synthetic musk described above is blended in the base layer to be described later to be a patch according to the present invention, but the content of the synthetic musk in the base layer is not particularly limited, but per 100 parts by weight of the base layer 0.0001 to 10 parts by weight, preferably 0.001 to 7 parts by weight, and more preferably 0.01 to 5 parts by weight. If the amount is less than 0.0001 parts by weight, it is difficult to exhibit the hair-growth effect. If the amount exceeds 10 parts by weight, not only a further hair-growth effect can be obtained, but a musk-like fragrance becomes strong.
本発明に係る貼布剤は有効成分である合成ムスクを含有する。貼布剤に育毛剤の有効成分を含有することにより、長時間にわたって有効成分の一定量を徐々に経皮吸収させることができるので、優れた育毛効果を得ることができる。 The patch according to the present invention contains a synthetic musk which is an active ingredient. By containing the active ingredient of the hair restorer in the patch, a certain amount of the active ingredient can be gradually percutaneously absorbed over a long period of time, so that an excellent hair restoring effect can be obtained.
本発明に係る貼布剤は支持体と、この支持体に積層又は含浸された基剤層とからなり、有効成分である合成ムスクは基剤層に含有される。
支持体は通常の貼布剤に用いられる支持体であればよく、例えば、非伸縮性又は伸縮性のフィルム、不織布、編布などを例示することができる。
支持体の材質としては、ポリエチレン、ポリエステル、ポリプロピレン、ポリエチレンテレフタレート、ポリブチレンテレフタレート、ポリエチレンナフタレート、ポリスチレン、ナイロン、綿、レーヨン、レーヨン/ポリエチレンテレフタレート、ポリアクリロニトリル、ポリビニルアルコール、アクリル系樹脂、ポリウレタン、スチレン−イソプレン−スチレンブロック共重合体、スチレン−ブタジエン−スチレンブロック共重合体、スチレン−エチレン−プロピレン−スチレンブロック共重合体、スチレン−ブタジエンゴム、エチレン−酢酸ビニル共重合体、セロハン等を例示することができる。
また支持体には高分子フィルムを積層することができる。高分子フィルムとしては、ポリエチレン、ポリプロピレン、ポリエステル、ポリアミド、ポリビニルアルコール、ポリ塩化ビニル、ポリ塩化ビニリデン、ポリウレタン、ポリスチレン、エチレン−酢酸ビニル共重合体、ポリカーボネートなどを例示することができる。
支持体の厚さは特に限定されないが、1μm〜1cm、より好ましくは100μm〜1000μmとされる。
The patch according to the present invention comprises a support and a base layer laminated or impregnated on the support, and a synthetic musk as an active ingredient is contained in the base layer.
The support body should just be a support body used for a normal patch, for example, a non-stretchable or stretchable film, a nonwoven fabric, a knitted fabric etc. can be illustrated.
Support materials include polyethylene, polyester, polypropylene, polyethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate, polystyrene, nylon, cotton, rayon, rayon / polyethylene terephthalate, polyacrylonitrile, polyvinyl alcohol, acrylic resin, polyurethane, styrene. -Isoprene-styrene block copolymer, styrene-butadiene-styrene block copolymer, styrene-ethylene-propylene-styrene block copolymer, styrene-butadiene rubber, ethylene-vinyl acetate copolymer, cellophane, etc. Can do.
A polymer film can be laminated on the support. Examples of the polymer film include polyethylene, polypropylene, polyester, polyamide, polyvinyl alcohol, polyvinyl chloride, polyvinylidene chloride, polyurethane, polystyrene, ethylene-vinyl acetate copolymer, and polycarbonate.
The thickness of the support is not particularly limited, but is 1 μm to 1 cm, more preferably 100 μm to 1000 μm.
支持体には基剤層が積層又は含浸される。基剤層は皮膚面に対する粘着性に優れ、皮膚局所への適用が容易であり、しかも、有効成分の溶解性に優れるとともに、有効成分を徐々に放出して経皮吸収させることができるものである。本発明では、一般的な貼布剤の基剤層であればいずれも使用することができる。
具体的には、粘着剤又は水溶性高分子などから構成された基剤層を例示することができる。
The support is laminated or impregnated with a base layer. The base layer has excellent adhesion to the skin surface, is easy to apply to the skin, and has excellent solubility of the active ingredient, and can be gradually released to absorb the active ingredient. is there. In the present invention, any base layer of a general patch can be used.
Specifically, a base layer composed of an adhesive or a water-soluble polymer can be exemplified.
粘着剤としては、ゴム系粘着剤、酢酸ビニル系粘着剤、エチレン−酢酸ビニル系粘着剤、塩化ビニル系粘着剤、アクリル系粘着剤、ポリアミド系粘着剤、ポリエチレン系粘着剤、ポリサルファイド粘着剤などを例示することができる。
基剤層を粘着剤から構成する場合、粘着剤の含有量は特に限定されないが、基剤層100重量部当り、5〜50重量部、好ましくは10〜40重量部、より好ましくは15〜35重量部である。
Adhesives include rubber adhesives, vinyl acetate adhesives, ethylene-vinyl acetate adhesives, vinyl chloride adhesives, acrylic adhesives, polyamide adhesives, polyethylene adhesives, polysulfide adhesives, etc. It can be illustrated.
When the base layer is composed of a pressure-sensitive adhesive, the content of the pressure-sensitive adhesive is not particularly limited, but is 5 to 50 parts by weight, preferably 10 to 40 parts by weight, more preferably 15 to 35 parts per 100 parts by weight of the base layer. Parts by weight.
水溶性高分子としては、天然高分子、半合成高分子、合成高分子を例示することができる。
天然高分子としては、ゼラチン、澱粉、寒天、グルコマンナン、アルギン酸又はその塩、アラビアガム、トラガントガム、ローカストビーンガム、アカシアガム、グアガム、カラギーナンなどを例示することができる。
Examples of water-soluble polymers include natural polymers, semi-synthetic polymers, and synthetic polymers.
Examples of the natural polymer include gelatin, starch, agar, glucomannan, alginic acid or a salt thereof, gum arabic, tragacanth gum, locust bean gum, gum acacia, guar gum, carrageenan and the like.
半合成高分子としては、メチルセルロース、メチルセルロースナトリウム、エチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、カルボキシメチルセルロースナトリウム、デキストリンなどを例示することができる。 Examples of the semisynthetic polymer include methyl cellulose, methyl cellulose sodium, ethyl cellulose, hydroxyethyl cellulose, carboxymethyl cellulose, carboxymethyl cellulose sodium, and dextrin.
合成高分子としては、ポリアクリル酸又はその塩、ポリビニルアルコール、ポリビニルピロリドン、ポリビニルメタクリレート、メチルビニルエーテル−無水マレイン酸共重合体、カルボキシビニルポリマー、ポリエチレンオキサイド、イソブチレン−無水マレイン酸共重合体などを例示することができる。 Examples of synthetic polymers include polyacrylic acid or salts thereof, polyvinyl alcohol, polyvinyl pyrrolidone, polyvinyl methacrylate, methyl vinyl ether-maleic anhydride copolymer, carboxyvinyl polymer, polyethylene oxide, isobutylene-maleic anhydride copolymer, etc. can do.
上述した水溶性高分子は公知の架橋剤又は重合剤で処理されていても構わない。また上述した水溶性高分子は一種又は二種以上を配合することができる。
基剤層を水溶性高分子から構成する場合、水溶性高分子の含有量は、基剤層100重量部当り、1〜20重量部、好ましくは3〜15重量部、より好ましくは5〜10重量部である。
The water-soluble polymer described above may be treated with a known crosslinking agent or polymerization agent. Moreover, the water-soluble polymer mentioned above can mix | blend 1 type, or 2 or more types.
When the base layer is composed of a water-soluble polymer, the content of the water-soluble polymer is 1 to 20 parts by weight, preferably 3 to 15 parts by weight, more preferably 5 to 10 parts per 100 parts by weight of the base layer. Parts by weight.
さらに、本発明では基剤層に必要に応じて、水、溶解剤、経皮吸収促進剤、保湿剤、皮膚刺激緩和剤、界面活性剤などを配合することができる。 Furthermore, in the present invention, water, a solubilizer, a transdermal absorption promoter, a moisturizer, a skin irritation relieving agent, a surfactant and the like can be blended in the base layer as necessary.
基剤層に水を含有する場合、水の含有量は、基剤層100重量部当り、20〜80重量部、好ましくは30〜70重量部、より好ましくは40〜60重量部である。 When water is contained in the base layer, the water content is 20 to 80 parts by weight, preferably 30 to 70 parts by weight, and more preferably 40 to 60 parts by weight per 100 parts by weight of the base layer.
溶解剤としては、オレイン酸、炭酸プロピレン、プロピレングリコール、ポリエチレングリコール、ミリスチン酸イソプロピル、ミリスチン酸ブチル、パルミチン酸イソプロピル、パルミチン酸セチル、ステアリン酸ブチル、ステアリン酸イソセチル、セバシン酸ジエチル、セバシン酸ジイソプロピル、リノール酸エチル、リノール酸イソプロピル、サリチル酸メチル、サリチル酸グリコールベンジルアルコール、N−メチル−2−ピロリドン、オレイルアルコール、ジメチルスルホキシド、ハッカ油、ユーカリ油、ヒマシ油、リモネン等を例示することができる。
溶解剤を配合する場合、上述した溶解剤のうちの一種又は二種以上を配合することができる。
溶解剤の含有量は、基剤層100重量部当り、0.01〜10重量部、好ましくは0.05〜7重量部、より好ましくは0.1〜5重量部である。
Soluble agents include oleic acid, propylene carbonate, propylene glycol, polyethylene glycol, isopropyl myristate, butyl myristate, isopropyl palmitate, cetyl palmitate, butyl stearate, isocetyl stearate, diethyl sebacate, diisopropyl sebacate, linol Examples thereof include ethyl acid, isopropyl linoleate, methyl salicylate, glycol benzyl alcohol salicylate, N-methyl-2-pyrrolidone, oleyl alcohol, dimethyl sulfoxide, peppermint oil, eucalyptus oil, castor oil, limonene and the like.
When mix | blending a solubilizer, the 1 type (s) or 2 or more types of the above-mentioned solubilizers can be mix | blended.
The content of the dissolving agent is 0.01 to 10 parts by weight, preferably 0.05 to 7 parts by weight, more preferably 0.1 to 5 parts by weight, per 100 parts by weight of the base layer.
経皮吸収促進剤としては、ジイソプロピルアジペート、レシチン、スクワラン、スクワレン、エイゾン、メントール、ポリエチレングリコール、ミリスチン酸イソプロピル、クロタミトン、ハッカ油、ユーカリ油、リモネン、オレイン酸、リノレイン酸ジイソプロピルアジペート、ジメチルスルホキシド等を例示することができる。
経皮吸収促進剤を配合する場合、上述した経皮吸収促進剤のうちの一種又は二種以上を配合することができる。
経皮吸収促進剤の含有量は、基剤層100重量部当り、0.01〜10重量部、好ましくは0.05〜7重量部、より好ましくは0.5〜5重量部である。
As a transdermal absorption enhancer, diisopropyl adipate, lecithin, squalane, squalene, azone, menthol, polyethylene glycol, isopropyl myristate, crotamiton, mint oil, eucalyptus oil, limonene, oleic acid, diisopropyl adipate linoleate, dimethyl sulfoxide, etc. It can be illustrated.
When blending a percutaneous absorption enhancer, one or more of the percutaneous absorption enhancers described above can be blended.
The content of the transdermal absorption enhancer is 0.01 to 10 parts by weight, preferably 0.05 to 7 parts by weight, more preferably 0.5 to 5 parts by weight per 100 parts by weight of the base layer.
保湿剤としては、グリセリン、ソルビトール、乳酸、尿素、プロピレングリコール、エチレングリコール、ジエチレングリコール、トリエチレングリコール、ポリエチレングリコール、1,3−ブチレングリコール等を例示することができる。
保湿剤を配合する場合、上述した保湿剤のうちの一種又は二種以上を配合することができる。
保湿剤の含有量は、基剤層100重量部当り、10〜70重量部、好ましくは20〜60重量部、より好ましくは30〜55重量部である。
Examples of the humectant include glycerin, sorbitol, lactic acid, urea, propylene glycol, ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, 1,3-butylene glycol and the like.
When mix | blending a moisturizer, the 1 type (s) or 2 or more types of the moisturizer mentioned above can be mix | blended.
The content of the humectant is 10 to 70 parts by weight, preferably 20 to 60 parts by weight, more preferably 30 to 55 parts by weight per 100 parts by weight of the base layer.
皮膚刺激緩和剤としては、塩酸ジフェンヒドラミン、タンニン酸ジフェンヒドラミン、マレイン酸クロルフェラミン、マレイン酸フェニラミン、アンレキサノクス、イブシラスト、アゼラスチン、オキサトミド、クロモグリク酸塩、タザノラスト、テルフェナジン、トラニラスト、フマル酸ケトチフェン、レビリナスト、グリチルリチン酸、グリチルレチン酸、シクロデキストリンなどを例示することができる。
皮膚刺激緩和剤を配合する場合、上述した皮膚刺激緩和剤のうちの一種又は二種以上を配合することができる。
皮膚刺激緩和剤の含有量は、基剤層100重量部当り、0.01〜10重量部、好ましくは0.05〜7重量部、より好ましくは0.1〜5重量部である。
Skin irritants include diphenhydramine hydrochloride, diphenhydramine tannate, chlorferamine maleate, pheniramine maleate, amlexanox, ibucilast, azelastine, oxatomide, cromoglycate, tazanolast, terfenadine, tranilast, ketotifen fumarate, levirinast, glycyrrhizin Examples thereof include glycyrrhetinic acid and cyclodextrin.
When mix | blending a skin irritation reducing agent, the 1 type (s) or 2 or more types of the skin irritation reducing agents mentioned above can be mix | blended.
The content of the skin irritation mitigating agent is 0.01 to 10 parts by weight, preferably 0.05 to 7 parts by weight, more preferably 0.1 to 5 parts by weight per 100 parts by weight of the base layer.
界面活性剤としては、ポリオキシエチレングリコール脂肪酸エステル、プロピレングリコール脂肪酸エステル、グリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンステロール、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテルなどを例示することができる。
界面活性剤を配合する場合、上述した界面活性剤のうちの一種又は二種以上を配合することができる。
界面活性剤の含有量は、基剤層100重量部当り、0.01〜10重量部、好ましくは0.05〜7重量部、より好ましくは0.1〜5重量部である。
Surfactants include polyoxyethylene glycol fatty acid ester, propylene glycol fatty acid ester, glycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyglycerin fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbit fatty acid Examples include ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene sterol, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene alkylphenyl ether, and the like.
When mix | blending surfactant, the 1 type (s) or 2 or more types of the surfactant mentioned above can be mix | blended.
The content of the surfactant is 0.01 to 10 parts by weight, preferably 0.05 to 7 parts by weight, more preferably 0.1 to 5 parts by weight per 100 parts by weight of the base layer.
さらに本発明では、必要に応じて、アスコルビン酸、ステアリン酸エステル、没食子酸エステル、エテド酸塩、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソールなどの酸化防止剤、チモール、塩化ベンザルコニウム、パラベン等の防腐剤、リン酸、ホウ酸、クエン酸、酢酸、リンゴ酸、酒石酸、乳酸、水酸化ナトリウム、ジエタノールアミン、トリエタノールアミン、ジイソプロパノールアミンなどのpH調整剤、カオリン、酸化チタン、タルク、ベントナイト、酸化亜鉛、モンモリロナイト、無水ケイ酸などの無機粉体、ポリブテン、天然ラテックス、酢酸ビニルエマルジョン、ポリアクリル酸エステルエマルジョン、ポリアクリル酸エマルジョンなどの粘着付与剤を、適宜任意に配合することができる。 Furthermore, in the present invention, an antioxidant such as ascorbic acid, stearic acid ester, gallic acid ester, etedate, dibutylhydroxytoluene, butylhydroxyanisole, and a preservative such as thymol, benzalkonium chloride, paraben, etc. PH adjusters such as phosphoric acid, boric acid, citric acid, acetic acid, malic acid, tartaric acid, lactic acid, sodium hydroxide, diethanolamine, triethanolamine, diisopropanolamine, kaolin, titanium oxide, talc, bentonite, zinc oxide, Tackifiers such as inorganic powders such as montmorillonite and silicic anhydride, polybutene, natural latex, vinyl acetate emulsion, polyacrylic ester emulsion, and polyacrylic acid emulsion can be arbitrarily blended as appropriate.
基剤層の露出面は剥離層によって被覆、保護することが望ましい。剥離層としては、使用時に基剤層から容易に剥離することができるものであれば特に限定されず、例えば基剤層と接触する面にシリコーン樹脂、フッ素樹脂等を塗布することによって剥離処理を施した、ポリエステル、ポリ塩化ビニル、ポリ塩化ビニリデン、ポリエチレンテレフタレート等のフィルムなどを例示することができる。 It is desirable to cover and protect the exposed surface of the base layer with a release layer. The release layer is not particularly limited as long as it can be easily peeled off from the base layer at the time of use. Examples thereof include films of polyester, polyvinyl chloride, polyvinylidene chloride, polyethylene terephthalate, and the like.
本発明に係る貼布剤は皮膚局所に貼付して使用する。皮膚局所に貼付された貼布剤は基剤層に含まれる有効成分であるムスク様香気を有する化合物を長時間にわたって徐々に放出して有効成分を経皮吸収させることができ、優れた育毛効果を発揮することができる。
本発明に係る貼布剤の適用箇所は特に限定されず、頭、腕、脚、腰、肩等の人体の各部全てに好適に適用することができる。
The patch according to the present invention is used after being applied to the skin topic. The patch applied to the skin top can release the compound with musk-like fragrance, which is an active ingredient contained in the base layer, gradually over a long period of time to absorb the active ingredient, and has excellent hair growth effect Can be demonstrated.
The application location of the patch according to the present invention is not particularly limited, and can be suitably applied to all parts of the human body such as the head, arms, legs, waist, and shoulder.
以下、本発明を実施例に基づき説明するが、本発明はこれらの実施例に何ら限定されるものではない。尚、配合量は重量%である。 EXAMPLES Hereinafter, although this invention is demonstrated based on an Example, this invention is not limited to these Examples at all. In addition, a compounding quantity is weight%.
(試料の調製)
以下の組成からなる基剤に表1に記載の合成ムスクを加えたものと、厚さ100μmのポリエチレン製の織布からなる支持体とを用いて、常法に従い実施例の各貼布剤を調製した。尚、合成ムスクを全く含有していない対照例の貼布剤も同様に調製した。
<基剤の組成>
ポリアクリル酸ナトリウム 5.0
カルボキシメチルセルロースナトリウム 3.0
酒石酸 0.5
D−ソルビトール 20
グリセリン 20
ゼラチン 3.0
水酸化アルミニウム 0.5
メチルパラベン 0.1
精製水 適量
合成ムスク 0.35
合計 100.0重量%
(Sample preparation)
Using each of the bases composed of the following composition and the synthetic musk described in Table 1 and a support made of a woven fabric made of polyethylene having a thickness of 100 μm, each patch of the examples according to a conventional method. Prepared. In addition, the patch of the control example which does not contain a synthetic musk at all was prepared similarly.
<Base composition>
Sodium polyacrylate 5.0
Sodium carboxymethylcellulose 3.0
Tartaric acid 0.5
D-sorbitol 20
Glycerin 20
Gelatin 3.0
Aluminum hydroxide 0.5
Methylparaben 0.1
Purified water
Synthetic musk 0.35
Total 100.0% by weight
(試験例)
18〜40歳の脱毛症の男性を対象に、円周3cmの円形に切断した各貼布剤を左肩部に貼付(朝と晩の一日二回、貼付した貼布剤を交換)してもらい、試験開始から3ヶ月後の貼布剤を貼った箇所の毛髪の本数の増減について調べ、以下の評価基準に従い、評価した。結果を表1に記載する。
<評価基準>
試験開始前と試験終了後の毛髪の増加率は、60%以上であった。・・・A
試験開始前と試験終了後の毛髪の増加率は、45〜60%であった。・・B
試験開始前と試験終了後の毛髪の増加率は、30〜45%であった。・・C
試験開始前と試験終了後の毛髪の増加率は、0〜30%であった。・・・D
試験開始前と試験終了後の毛髪の増加率は、0%であった。・・・・・・E
(Test example)
For each adolescent male aged 18 to 40 years, apply each patch cut into a circle with a circumference of 3 cm on the left shoulder (change the applied patch twice a day in the morning and evening) And the increase / decrease in the number of hairs at the location where the patch was applied 3 months after the start of the test was examined and evaluated according to the following evaluation criteria. The results are listed in Table 1.
<Evaluation criteria>
The increase rate of hair before and after the test was 60% or more. ... A
The increase rate of hair before and after the test was 45 to 60%. ..B
The increase rate of hair before and after the test was 30 to 45%. ..C
The increase rate of hair before and after the test was 0 to 30%. ... D
The increase rate of the hair before the start of the test and after the end of the test was 0%.・ ・ ・ ・ ・ ・ E
表1に示されるように、合成ムスクを配合した各実施例の試料では、毛髪数の増加が確認された。一方、合成ムスクを全く含有しない対照例の試料では、毛髪数の有意な増加は確認されず、合成ムスクが育毛効果を有することが確認された。
As shown in Table 1, an increase in the number of hairs was confirmed in the samples of each Example blended with the synthetic musk. On the other hand, in the control sample containing no synthetic musk, no significant increase in the number of hairs was confirmed, confirming that the synthetic musk had a hair-growth effect.
Claims (3)
(A)大環状合成ムスク(A) Macrocyclic synthetic musk
シベトン(9−シクロペンタデセン−1−オン)、シクロペンタデカノン、シクロヘキサデセノン(5−シクロヘキサデセン−1−オン)、シクロペンタデカノリド、12−ケトシクロペンタデカノリド(オキサシクロヘキサデカン−2,13−ジオン)、シクロヘキサデカノリド、シクロヘキサデセノリド(7−シクロヘキサデセノリド)、12−オキサ−16−ヘキサデカノリド、11−オキサ−16−ヘキサデカノリド、10−オキサ−16−ヘキサデカノリド、エチレンプラシレート、エチレンドデカンジオエート Cybeton (9-cyclopentadecene-1-one), cyclopentadecanone, cyclohexadecenone (5-cyclohexadecene-1-one), cyclopentadecanolide, 12-ketocyclopentadecanolide (oxacyclohexadecane) -2,13-dione), cyclohexadecanolide, cyclohexadecenolide (7-cyclohexadecenolide), 12-oxa-16-hexadecanolide, 11-oxa-16-hexadecanolide, 10-oxa-16-hexadecanolide , Ethylene plasylate, ethylene dodecanedioate
(B)ニトロ系合成ムスク(B) Nitro-based synthetic musk
ムスクケトン(2,6−ジニトロ−3,5−ジメチル−4−t−ブチルベンゼン)、ムスクキシロール(2,4,6−トリニトロ−5−t−ブチルベンゼン)、ムスクアンブレット(2,6−ジニトロ−3−メトキシ−1−メチル−4−t−ブチルベンゼン)、ムスクチベテン(2,6−ジニトロ−3,4,5−トリメチル−t−ブチルベンゼン)、ムスクモスケン(1,1,3,3,5−ペンタメチル−4,6−ジニトロインダン) Musk ketone (2,6-dinitro-3,5-dimethyl-4-tert-butylbenzene), musk xylol (2,4,6-trinitro-5-tert-butylbenzene), musk ambullet (2,6-dinitro -3-Methoxy-1-methyl-4-t-butylbenzene), Muscutibeten (2,6-dinitro-3,4,5-trimethyl-t-butylbenzene), Musk Mosken (1,1,3,3,5) -Pentamethyl-4,6-dinitroindane)
(C)インダン系合成ムスク(C) Indan synthetic musk
6−アセチルヘキサメチルインダリン(6−アセチル−1,1,2,3,3,5−ヘキサメチルインダン)、4−アセチルジメチル−t−ブチルインダリン(4−アセチル−6−t−ブチル−1,1−ジメチルインダリン)、5−アセチルテトラメチルイソプロピルインダン(5−アセチル−3−イソプロピル−1,1,2,6−テトラメチルインダン) 6-acetylhexamethylindarin (6-acetyl-1,1,2,3,3,5-hexamethylindane), 4-acetyldimethyl-t-butylindarin (4-acetyl-6-t-butyl-) 1,1-dimethylindyne), 5-acetyltetramethylisopropylindane (5-acetyl-3-isopropyl-1,1,2,6-tetramethylindane)
(D)テトラリン系合成ムスク(D) Tetralin-based synthetic musk
6−アセチルヘキサテトラリン(6−アセチル−1,1,2,4,4,7−ヘキサメチルテトラリン)、ヘキサメチルヘキサヒドロシクロペンタベンゾピラン(4,6,6,7,8,8−ヘキサメチル−1,3,4,6,7,8−ヘキサヒドロシクロペンタベンゾピラン) 6-acetylhexatetralin (6-acetyl-1,1,2,4,4,7-hexamethyltetralin), hexamethylhexahydrocyclopentabenzopyran (4,6,6,7,8,8-hexamethyl- 1,3,4,6,7,8-hexahydrocyclopentabenzopyran)
(A)大環状合成ムスク(A) Macrocyclic synthetic musk
ムスコン(3−メチルシクロペンタデカノン)、シベトン(9−シクロペンタデセン−1−オン)、シクロペンタデカノン、シクロヘキサデセノン(5−シクロヘキサデセン−1−オン)、シクロペンタデカノリド、12−ケトシクロペンタデカノリド(オキサシクロヘキサデカン−2,13−ジオン)、シクロヘキサデカノリド、シクロヘキサデセノリド(7−シクロヘキサデセノリド)、12−オキサ−16−ヘキサデカノリド、11−オキサ−16−ヘキサデカノリド、10−オキサ−16−ヘキサデカノリド、エチレンプラシレート、エチレンドデカンジオエート Muscon (3-methylcyclopentadecanone), civeton (9-cyclopentadecene-1-one), cyclopentadecanone, cyclohexadecenone (5-cyclohexadecen-1-one), cyclopentadecanolide, 12 -Ketocyclopentadecanolide (oxacyclohexadecane-2,13-dione), cyclohexadecanolide, cyclohexadecenolide (7-cyclohexadecenolide), 12-oxa-16-hexadecanolide, 11-oxa- 16-hexadecanolide, 10-oxa-16-hexadecanolide, ethylene plasylate, ethylenedodecanedioate
(B)ニトロ系合成ムスク(B) Nitro-based synthetic musk
ムスクケトン(2,6−ジニトロ−3,5−ジメチル−4−t−ブチルベンゼン)、ムスクキシロール(2,4,6−トリニトロ−5−t−ブチルベンゼン)、ムスクアンブレット(2,6−ジニトロ−3−メトキシ−1−メチル−4−t−ブチルベンゼン)、ムスクチベテン(2,6−ジニトロ−3,4,5−トリメチル−t−ブチルベンゼン)、ムスクモスケン(1,1,3,3,5−ペンタメチル−4,6−ジニトロインダン) Musk ketone (2,6-dinitro-3,5-dimethyl-4-tert-butylbenzene), musk xylol (2,4,6-trinitro-5-tert-butylbenzene), musk ambullet (2,6-dinitro -3-Methoxy-1-methyl-4-t-butylbenzene), Muscutibeten (2,6-dinitro-3,4,5-trimethyl-t-butylbenzene), Musk Mosken (1,1,3,3,5) -Pentamethyl-4,6-dinitroindane)
(C)インダン系合成ムスク(C) Indan synthetic musk
6−アセチルヘキサメチルインダリン(6−アセチル−1,1,2,3,3,5−ヘキサメチルインダン)、4−アセチルジメチル−t−ブチルインダリン(4−アセチル−6−t−ブチル−1,1−ジメチルインダリン)、5−アセチルテトラメチルイソプロピルインダン(5−アセチル−3−イソプロピル−1,1,2,6−テトラメチルインダン) 6-acetylhexamethylindarin (6-acetyl-1,1,2,3,3,5-hexamethylindane), 4-acetyldimethyl-t-butylindarin (4-acetyl-6-t-butyl-) 1,1-dimethylindyne), 5-acetyltetramethylisopropylindane (5-acetyl-3-isopropyl-1,1,2,6-tetramethylindane)
(D)テトラリン系合成ムスク(D) Tetralin-based synthetic musk
6−アセチルヘキサテトラリン(6−アセチル−1,1,2,4,4,7−ヘキサメチルテトラリン)、ヘキサメチルヘキサヒドロシクロペンタベンゾピラン(4,6,6,7,8,8−ヘキサメチル−1,3,4,6,7,8−ヘキサヒドロシクロペンタベンゾピラン) 6-acetylhexatetralin (6-acetyl-1,1,2,4,4,7-hexamethyltetralin), hexamethylhexahydrocyclopentabenzopyran (4,6,6,7,8,8-hexamethyl- 1,3,4,6,7,8-hexahydrocyclopentabenzopyran)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004029878A JP4301443B2 (en) | 2004-02-05 | 2004-02-05 | Hair growth agent and patch containing the hair growth agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004029878A JP4301443B2 (en) | 2004-02-05 | 2004-02-05 | Hair growth agent and patch containing the hair growth agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005220077A JP2005220077A (en) | 2005-08-18 |
| JP4301443B2 true JP4301443B2 (en) | 2009-07-22 |
Family
ID=34995988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004029878A Expired - Fee Related JP4301443B2 (en) | 2004-02-05 | 2004-02-05 | Hair growth agent and patch containing the hair growth agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4301443B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010215579A (en) * | 2009-03-18 | 2010-09-30 | Michiharu Sasaki | Hair nourishing liquid |
| JP5754565B2 (en) * | 2009-04-07 | 2015-07-29 | 株式会社ホームズ | Hair restorer composition, effect enhancer for hair restorer and method for producing hair restorer |
-
2004
- 2004-02-05 JP JP2004029878A patent/JP4301443B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005220077A (en) | 2005-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU717000B2 (en) | Skin toning formulation | |
| CA1085735A (en) | Alkyl lactate with alkylene glycol as acne composition | |
| AU2005215214B2 (en) | Skincare compositions | |
| JP2562455B2 (en) | Improved osmotic topical pharmaceutical composition | |
| EP1073446B1 (en) | Skin whitening composition | |
| AU780426B2 (en) | Method for reducing the appearance of dark circles under the eyes | |
| MX2008016306A (en) | Transdermal delivery of oleocanthal for relief of inflammation. | |
| JP5290582B2 (en) | Pharmaceutical composition for nail | |
| JP4596751B2 (en) | Anti-inflammatory analgesic patch | |
| JP2002506821A (en) | How to treat skin irritation | |
| AU732330B2 (en) | Device for topical treatment of acne and its method of manufacture | |
| WO2000000162A1 (en) | Skin whitening composition | |
| CA2338859A1 (en) | Estradiol-containing patch for transdermal administration of hormones | |
| AU740303B2 (en) | External preparations containing watercress extract | |
| CA3047927A1 (en) | Compositions and methods for treating skin conditions using light and glucosamine hydrochloride | |
| AU9742301A (en) | Treatment for skin | |
| JP4301443B2 (en) | Hair growth agent and patch containing the hair growth agent | |
| JPH0665049A (en) | External preparation for skin | |
| US20130338226A1 (en) | Ingenols for treating seborrheic keratosis | |
| JP5485495B2 (en) | Patch | |
| JP2000044427A (en) | Sheet cosmetics | |
| KR20000022879A (en) | Active-agent delivery system comprising, on a film structure, a composition based on a salicylic acid derivative, and its uses | |
| JP2003040703A (en) | Pest repellent for human body | |
| JP2006056845A (en) | Plaster agent containing extract of plant of rose family | |
| JP2001131050A (en) | Skin cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070118 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20081030 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081105 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081219 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090126 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090303 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090325 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090416 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120501 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |